About
Contact & Profiles
A5026084626
Research Areas
- Cancer Immunotherapy and Biomarkers
- Dermatologic Treatments and Research
- melanin and skin pigmentation
- Immunotherapy and Immune Responses
- Cutaneous Melanoma Detection and Management
- Skin Protection and Aging
- Skin and Cellular Biology Research
- Retinoids in leukemia and cellular processes
Peking University First Hospital
2022-2024
Peking University
2022-2024
10.1016/j.jdermsci.2024.08.002
article
EN
Journal of Dermatological Science
2024-08-17
10.1016/j.jid.2022.08.053
article
EN
publisher-specific-oa
Journal of Investigative Dermatology
2022-09-17
Background: Anti-programmed cell death ligand-1 (anti-PD-L1) immunotherapy is often used for advanced urothelial carcinoma and melanoma, including amelanotic a relatively rare subtype with little to no pigment in the tumor cells. However, cellular heterogeneity of melanoma during or after anti-PD-L1 treatments has not been described. Purpose: To investigate acral exposure. Methods: We evaluated subtle visual changes by dermoscopy performed pathological examination analyze microscopic...
10.2147/ccid.s404381
article
EN
cc-by-nc
Clinical Cosmetic and Investigational Dermatology
2023-04-01
Coming Soon ...